Check out your Company Bowl for anonymous work chats.
When wastewater data showed an uncharacteristic spike in influenza A, Verily scientists, in partnership with WastewaterSCAN, developed an H5 assay to help trace the highly pathogenic H5N1 virus infection. We’re currently testing for H5 at more than a hundred wastewater sites in over 40 states across the country. Read more in Bloomberg about Verily’s wastewater program and our work with the Centers for Disease Control and Prevention.
One of the goals of our LGBTv employee resource group (ERG) is to foster a community where members feel supported, safe and that they belong. Throughout the year the ERG hosts social events and gathers to talk about important issues surrounding health and representation. This year for hashtag#PrideMonth the LGBTv ERG wanted to expand beyond Verily and continue building community among members and allies by getting together with fellow Alphabet companies, Waymo and X, the moonshot factory, to celebrate Pride.
We are proud to partner with Aligning Science Across Parkinson’s | ASAP on the newly launched ASAP CRN Cloud, a groundbreaking data-sharing platform available to the entire Parkinson’s Disease research community. Created in collaboration with The Michael J. Fox Foundation for Parkinson's Research, DNAstack and DataTecnica LLC, the tool includes a unique dataset of human postmortem-derived brain samples for analysis. ASAP CRN Cloud uses Verily Viewpoint Workbench, a collaborative environment where scientists worldwide can securely access, analyze and share multimodal Parkinson’s data, in order to advance understanding of the disease and accelerate research.
In a recent study, researchers from Verily and Google Research compared pre-translation with direct inference of large language models (LLMs) on multilingual tasks. They showed that direct inference can be more efficient and effective in multilingual settings, alleviating the limitations of pre-translation.
From learning about the history of hashtag#Juneteenth to enjoying summer cookout dishes to supporting local black-owned businesses, these are just a few ways Veeps celebrated Juneteenth here at Verily. Thank you to our vBlack and Mosaic (allyship champions) ERGs for hosting such inspirational and educational events!
"As technology continues its quest to improve care by leveraging data sets, there are questions about bias and representation we must address. Modern techniques like deep learning and generative AI approaches must be designed to recognize these challenges,” said Andrew Trister, MD PhD, our Chief Medical and Scientific Officer, while at the inaugural HLTH Europe event this week. With co-panelists Gloria Seibert, Lucy Orr-Ewing, Ludovic d'Apréa and moderator LaShonda Anderson-Williams, they talked about the vast amount of healthcare data and how to overcome challenges to unlock its potential. Additionally, Dr. Trister noted: "We must build technology to allow people to generate data on their own outside of the healthcare system. We can augment data by patient reported outcomes via digital technology and wearables but only if the patient believes in the source and use of the results."
Benjamin Yaffe, our Head of Special Projects, had the honor of presenting Verily’s ongoing research and work in wastewater pathogen monitoring to this year’s cohort of the U.S. Air Force Institute of Technology Education With Industry Program. Over a ten-month period, the fellows focus on improving technical, professional and management skills by partnering with top-tier companies. In this session, the group learned how our approach to wastewater surveillance has expanded since the pandemic to a national scale, serving as a public health monitoring tool to detect new and emerging pathogens. Additionally, they discussed ways this technology could support USAF and broader DOD operational readiness and resilience.
At AHIP 2024 last week, Verily introduced Lightpath, a personalized and dynamic chronic care solution, which will pair an AI-fueled platform with access to a deep bench of clinical experts. It is planned to be available for open enrollment in early 2026 and will help health plan members manage diabetes, obesity, and additional metabolic conditions. “We plan for the program to analyze member data to determine when to adjust and pinpoint the level of intensity that is the best for them at different points in their health journey.” - Myoung Cha, Verily Chief Product Officer
How can we realize the potential of healthcare data to transform our lives? Where will healthcare data make the most impact? How do we access the potential goldmine? These questions and more will be discussed at HLTH Europe next week in the session featuring our Chief Medical and Scientific Officer Andrew Trister, MD PhD.
Today, Verily introduced Lightpath, a personalized, AI-powered chronic care solution that will be designed to meet the changing needs of health plans and their members. The first offering, Lightpath Metabolic, will provide dynamic programs to help members with cardiometabolic diseases achieve and maintain their health goals. It is planned to be available for open enrollment in early 2026.
